Cannabis Legalization in Canada Linked to Tripling of Schizophrenia Cases

11 months ago 11
  • Overall, the study highlights the urgent need for ongoing research into the long-term effects of cannabis policy on the prevalence of psychotic disorders.

  • A recent study has established a concerning link between Canada's cannabis legalization and a notable rise in schizophrenia cases associated with cannabis use disorder (CUD) in Ontario.

  • Analyzing electronic medical records from over 13.5 million Ontario residents between 2006 and 2022, the study found that new schizophrenia cases related to CUD nearly tripled following legalization.

  • The research specifically investigates the relationship between cannabis use disorder and schizophrenia in Canada, particularly after significant changes in cannabis policy.

  • Post-legalization, the number of individuals requiring hospital care for CUD surged by 270%, increasing from 1.3 to 4.6 per 1,000 people.

  • The population-attributable risk fraction (PARF) for CUD linked to schizophrenia rose dramatically from 3.7% before legalization to 10.3% during the legalization period, with young men aged 19-24 being particularly affected.

  • Among individuals diagnosed with CUD, 8.9% developed schizophrenia, a stark contrast to just 0.6% in the general population without CUD.

  • While the overall annual incidence of schizophrenia remained stable, the incidence of psychosis not otherwise specified (NOS) saw a significant increase of 83.7% after legalization.

  • The research raises alarms about the public health consequences of increased cannabis potency and usage, especially among younger populations.

  • Jodi Gilman from Massachusetts General Hospital emphasized the necessity for comprehensive epidemiological studies to evaluate the long-term mental health effects of cannabis legalization on vulnerable groups.

  • These findings underscore the critical need to consider the public health implications of cannabis legalization, particularly concerning mental health disorders.

  • Study investigator Daniel Myran cautioned that legalization does not mitigate the risks associated with cannabis use, similar to the dangers posed by legal substances like alcohol and tobacco.

  • Read Entire Article